Tang Capital Management as of Sept. 30, 2020
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 20 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 37.0 | $205M | 15M | 13.43 | |
| Rocket Pharmaceuticals (RCKT) | 12.3 | $68M | 3.0M | 22.86 | |
| Heron Therapeutics (HRTX) | 7.8 | $43M | 2.9M | 14.82 | |
| Biohaven Pharmaceutical Holding | 7.0 | $39M | 599k | 65.01 | |
| Anaptysbio Inc Common (ANAB) | 7.0 | $39M | 2.6M | 14.75 | |
| La Jolla Pharmaceuticl Com Par | 6.9 | $38M | 9.4M | 4.03 | |
| Bio Rad Labs Cl A (BIO) | 3.7 | $21M | 40k | 515.45 | |
| Relmada Therapeutics (RLMD) | 3.4 | $19M | 500k | 37.62 | |
| United Therapeutics Corporation (UTHR) | 2.9 | $16M | 160k | 101.00 | |
| Sangamo Biosciences (SGMO) | 2.7 | $15M | 1.6M | 9.45 | |
| Puma Biotechnology (PBYI) | 2.3 | $13M | 1.2M | 10.09 | |
| Coherus Biosciences (CHRS) | 1.8 | $10M | 550k | 18.34 | |
| Avrobio Ord (AVRO) | 1.6 | $9.1M | 700k | 13.02 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 1.2 | $6.8M | 500k | 13.60 | |
| Bctg Acquisition Corp | 0.9 | $4.9M | 469k | 10.36 | |
| Eagle Pharmaceuticals (EGRX) | 0.5 | $2.6M | 62k | 42.48 | |
| Vanda Pharmaceuticals (VNDA) | 0.3 | $1.8M | 191k | 9.66 | |
| Prothena Corp SHS (PRTA) | 0.3 | $1.8M | 179k | 9.99 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $751k | 113k | 6.65 | |
| Tenax Therapeutics Com New | 0.1 | $708k | 460k | 1.54 |
